CONFERENCE COVERAGE SERIES
Gladstone Workshop: ApoE4
San Francisco, California, U.S.A.
30 January 2012 – 01 February 2014
Considering the dramatic impact of its E4 allelic variant on Alzheimer’s disease risk, apolipoprotein E arguably has drawn scant attention from AD drug developers. At a workshop organized by the Gladstone Institute of Neurological Disease in San Francisco, researchers focused in on what makes the protein so harmful.
San Francisco: Tweaking Brain ApoE Reduces Aβ, Symptoms
Considering the dramatic impact of its E4 allelic variant on Alzheimer’s disease risk, apolipoprotein E arguably has drawn scant attention from AD drug developers...
San Francisco: GABA Neurons Blamed for Memory Loss in ApoE Mice
People carrying one copy of the ApoE4 gene variant are up to four times more likely to develop AD, but what makes the protein so harmful?...